MYCALCET TAB

Mycalcet Tab is a calcimimetic medication containing cinacalcet hydrochloride, designed to treat secondary hyperparathyroidism in patients with chronic kidney disease undergoing dialysis. By enhancing parathyroid cell sensitivity to serum calcium, it effectively lowers elevated parathyroid hormone (PTH) and calcium levels. This medication helps restore calcium-phosphorus balance, reducing complications associated with mineral metabolism disorders. It may decrease dependence on phosphate binders and vitamin D supplements in appropriate patients. Dosage is individualized based on baseline PTH and serum calcium measurements. Regular laboratory monitoring is essential to ensure therapeutic efficacy and safety. Use only as prescribed by your physician.